Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study

BACKGROUND: Although the effects of interleukin-17A (IL-17A) inhibition on the signs and symptoms of psoriatic arthritis (PsA) are well defined, little is known about its impact of local inflammatory and structural changes in the joints. The PSARTROS study was designed to elucidate the effects of IL...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Arthritis Res Ther
Main Authors: Kampylafka, Eleni, d’Oliveira, Isabelle, Linz, Christina, Lerchen, Veronika, Stemmler, Fabian, Simon, David, Englbrecht, Matthias, Sticherling, Michael, Rech, Jürgen, Kleyer, Arnd, Schett, Georg, Hueber, Axel J.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6063019/
https://ncbi.nlm.nih.gov/pubmed/30053825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-018-1653-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki